Search
for
Sort by
Research 31–60 of 1000+
- ACOS23O-001: Using Autologous Human Hair Follicular Stem Cells for Male Pattern Hair Loss (MPHL) & Female Pattern Hair Loss (FPHL) in Asian Populations
- Janus Kinase (JAK) Inhibitors in Dermatology: An Update and Critical Review
- Laser Treatment of Hair Loss: An Update and Literature Review
- Specific Attention Areas in Scar Management: Specific Scar Management Depending on Anatomical Features (Face, Hair, Breast, Hand, Joints, Foot)
- Efficacy and safety of different JAK inhibitors in the treatment of alopecia areata: a network meta-analysis
- Development and pilot-testing of the Alopecia Areata Assessment Tool (ALTO)
- Oxidative stress and alopecia areata
- Influence of climate factors on pediatric alopecia areata flares in Philadelphia, Pennsylvania
- A case of alopecia areata after rabies vaccination: unreported adverse effect?
- Associated comorbidities in pediatric patients with alopecia areata
- Modern Management Approaches for Alopecia Areata
- A consensus-based treatment algorithm for alopecia areata in adolescents and adults: integrating severity, quality of life, and disease dynamics
- Humanized CXCL12 antibody delays onset and modulates immune response in alopecia areata mice: insights from single-cell RNA sequencing
- Integrated single-cell chromatin and transcriptomic analyses of peripheral immune cells in patients with alopecia areata
- Janus kinase inhibitors for alopecia areata: a review of clinical data
- Safety of oral JAK inhibitors in treating alopecia areata: a systematic review and network meta-analysis
- Alopecia Areata Treatment Patterns and Satisfaction: Results of a Real-World Cross-Sectional Survey in Europe
- Association between genetically predicted rheumatoid arthritis and alopecia areata: a two-sample Mendelian randomization study
- Performance exploration of multi-gene panels of alopecia areata susceptibility and drug-binding targets
- Healthy individuals genetically at-risk for the development of Pemphigus vulgaris or Alopecia areata share disease-like cytokine dysregulation
- Upadacitinib in the treatment of a patient with the triad of atopic dermatitis, vitiligo, and alopecia areata: a case report and literature review
- Case Report: Paired vertex-occipital assessment reveals donor-area involvement in diffuse unpatterned alopecia
- Case Report: Multimodal contact immunotherapy in alopecia areata: long-term clinical experience in the JAK inhibitor era
- Global, regional, and national burden of alopecia areata in adolescents and young adults aged 10–24 years from 1990 to 2021: a trend analysis
- Association between SQSTM1 dysregulation and risk in alopecia areata: a Mendelian randomization study
- Longitudinal clinical course, treatment outcomes, and relapse patterns in alopecia areata: a prospective cohort study
- Psychometric validation of the Spanish alopecia areata–life impact questionnaire
- Alopecia areata: from immunopathogenesis to emerging therapeutic approaches
- Coexistence of bullous pemphigoid, intrahepatic cholangiocarcinoma, and alopecia areata: a case report of multifactorial autoimmunity in a surgical context
- Long-Term Efficacy and Safety of Ritlecitinib in Adults and Adolescents with Alopecia Areata: 3-Year Results from the ALLEGRO Phase 2b/3 and ALLEGRO-LT Phase 3 Clinical Studies